Literature DB >> 10211964

Human and most animal rotavirus strains do not require the presence of sialic acid on the cell surface for efficient infectivity.

M Ciarlet, M K Estes.   

Abstract

The outer capsid spike protein VP4 is the main rotavirus cell attachment protein, but the cellular receptor used by rotavirus to establish a productive infection remains unknown. Sialic acid (SA) residues on the cell surface have been shown to be required for efficient binding and infectivity of animal rotaviruses (ARVs), but not of human rotaviruses (HRVs). Since the SA dependence of only a limited number of strains has been tested to date, in this study a larger number of strains were tested to further investigate the involvement of SA in rotavirus infectivity. Following treatment of African green monkey kidney cell (MA104) monolayers with neuraminidase, productive infection of rotavirus was measured by immunofluorescence. The infectivity of all 14 HRVs tested was SA-independent. Ten of 15 ARVs tested were SA-independent, while only five were SA-dependent. These results indicate that most ARVs, like HRVs, infect permissive cells in an SA-independent manner, probably by a common cellular receptor.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10211964     DOI: 10.1099/0022-1317-80-4-943

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  64 in total

1.  Differential infection of polarized epithelial cell lines by sialic acid-dependent and sialic acid-independent rotavirus strains.

Authors:  M Ciarlet; S E Crawford; M K Estes
Journal:  J Virol       Date:  2001-12       Impact factor: 5.103

2.  Initial interaction of rotavirus strains with N-acetylneuraminic (sialic) acid residues on the cell surface correlates with VP4 genotype, not species of origin.

Authors:  Max Ciarlet; Juan E Ludert; Miren Iturriza-Gómara; Ferdinando Liprandi; James J Gray; Ulrich Desselberger; Mary K Estes
Journal:  J Virol       Date:  2002-04       Impact factor: 5.103

3.  Heat shock cognate protein 70 is involved in rotavirus cell entry.

Authors:  Carlos A Guerrero; Daniela Bouyssounade; Selene Zárate; Pavel Isa; Tomás López; Rafaela Espinosa; Pedro Romero; Ernesto Méndez; Susana López; Carlos F Arias
Journal:  J Virol       Date:  2002-04       Impact factor: 5.103

4.  Trypsin cleavage stabilizes the rotavirus VP4 spike.

Authors:  S E Crawford; S K Mukherjee; M K Estes; J A Lawton; A L Shaw; R F Ramig; B V Prasad
Journal:  J Virol       Date:  2001-07       Impact factor: 5.103

5.  VP7 mediates the interaction of rotaviruses with integrin alphavbeta3 through a novel integrin-binding site.

Authors:  Selene Zárate; Pedro Romero; Rafaela Espinosa; Carlos F Arias; Susana López
Journal:  J Virol       Date:  2004-10       Impact factor: 5.103

6.  Rotavirus anti-VP6 secretory immunoglobulin A contributes to protection via intracellular neutralization but not via immune exclusion.

Authors:  Blaise Corthésy; Yann Benureau; Clémentine Perrier; Cynthia Fourgeux; Nathalie Parez; Harry Greenberg; Isabelle Schwartz-Cornil
Journal:  J Virol       Date:  2006-09-06       Impact factor: 5.103

Review 7.  Carbohydrate recognition by rotaviruses.

Authors:  Xing Yu; Helen Blanchard
Journal:  J Struct Funct Genomics       Date:  2013-11-19

8.  Specificity and affinity of sialic acid binding by the rhesus rotavirus VP8* core.

Authors:  Philip R Dormitzer; Zhen-Yu J Sun; Ola Blixt; James C Paulson; Gerhard Wagner; Stephen C Harrison
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

9.  Porcine arterivirus infection of alveolar macrophages is mediated by sialic acid on the virus.

Authors:  Peter L Delputte; Hans J Nauwynck
Journal:  J Virol       Date:  2004-08       Impact factor: 5.103

10.  The VP8* domain of neonatal rotavirus strain G10P[11] binds to type II precursor glycans.

Authors:  Sasirekha Ramani; Nicolas W Cortes-Penfield; Liya Hu; Sue E Crawford; Rita Czako; David F Smith; Gagandeep Kang; Robert F Ramig; Jacques Le Pendu; B V Venkataram Prasad; Mary K Estes
Journal:  J Virol       Date:  2013-04-24       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.